Skip to Main Content
Back to News

Insider Sale: Pres & CEO of $RDNT Sells 500 Shares

Automated

Cornelis Wesdorp, the Pres & CEO of $RDNT, sold 500 shares of the company on 09-09-2025 for an estimated $35,995. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares of this class of stock. Following this trade, they now own 53,995 shares of this class of $RDNT stock.

$RDNT Insider Trading Activity

RDNT Insider Trades

$RDNT insiders have traded $RDNT stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $RDNT stock by insiders over the last 6 months:

  • RANJAN JAYANATHAN (Chief Information Officer) sold 65,598 shares for an estimated $4,427,865
  • NORMAN R HAMES (Pres and COO-West Operations) has made 0 purchases and 7 sales selling 28,447 shares for an estimated $1,603,620.
  • DAVID JEFFREY KATZ (EVP and Chief Legal Officer) sold 17,000 shares for an estimated $1,161,270
  • STEPHEN M FORTHUBER (Pres & COO-Eastern Operations) sold 18,820 shares for an estimated $1,135,598
  • MICHAEL N MURDOCK (EVP, Mergers and Acquisitions) sold 11,132 shares for an estimated $646,212
  • LAWRENCE L LEVITT sold 5,000 shares for an estimated $305,450
  • CORNELIS WESDORP (Pres & CEO, Digital Health) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $136,465.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RDNT Hedge Fund Activity

We have seen 191 institutional investors add shares of $RDNT stock to their portfolio, and 168 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RDNT Analyst Ratings

Wall Street analysts have issued reports on $RDNT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B. Riley Securities issued a "Buy" rating on 06/13/2025
  • Truist Securities issued a "Buy" rating on 04/11/2025
  • Barclays issued a "Overweight" rating on 03/24/2025

To track analyst ratings and price targets for $RDNT, check out Quiver Quantitative's $RDNT forecast page.

$RDNT Price Targets

Multiple analysts have issued price targets for $RDNT recently. We have seen 4 analysts offer price targets for $RDNT in the last 6 months, with a median target of $77.0.

Here are some recent targets:

  • Andrew Mok from Barclays set a target price of $79.0 on 09/03/2025
  • David Macdonald from Truist Securities set a target price of $81.0 on 09/03/2025
  • John Ransom from Raymond James set a target price of $75.0 on 08/13/2025
  • Yuan Zhi from B. Riley Securities set a target price of $69.0 on 06/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles